Verge Genomics Company
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Investors
Technology:
Bioinformatics, Biotechnology, Genetics, Health Care, Machine Learning, Neuroscience, Therapeutics
Industry:
AI, Early Drug Development, United States
Headquarters:
San Francisco, California, United States
Founded Date:
2015-01-01
Employees Number:
51-100
Funding Status:
Early Stage Venture
Investors Number:
26
Total Funding:
134120000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-12-16
Last Funding Type:
Series B
Register and Claim Ownership